1. Home
  2. Labeler Index
  3. Celgene Corporation
  4. 59572-515
  5. NDC Package Code: 59572-515-02 Abecma

NDC Package 59572-515-02 Abecma

Idecabtagene Vicleucel Suspension Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
59572-515-02
Package Description:
1 SUSPENSION in 1 BAG
Product Code:
59572-515
Proprietary Name:
Abecma
Non-Proprietary Name:
Idecabtagene Vicleucel
Substance Name:
Idecabtagene Vicleucel
Usage Information:
ABECMA is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
11-Digit NDC Billing Format:
59572051502
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2536434 - idecabtagene vicleucel 460000000 CELLS in 30 mL Injection
  • RxCUI: 2536434 - 30 ML idecabtagene vicleucel 15333333 CELLS/ML Injection
  • RxCUI: 2536434 - idecabtagene vicleucel 15333333 CELLS/ML per 30 ML Injection
  • RxCUI: 2536434 - idecabtagene vicleucel 460000000 CELLS per 30 ML Injection
  • RxCUI: 2536439 - Abecma 460000000 CELLS in 30 mL Injection
    • Product Type:
    Cellular Therapy
    Labeler Name:
    Celgene Corporation
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • IDECABTAGENE VICLEUCEL 300000000 1/1
    • Sample Package:
    No
    FDA Application Number:
    BLA125736
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    03-26-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 59572-515-02 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    59572051502Q2055Idecabtagene vicleucel carUP TO 460 MILLION AUTOLOGOUS ANTI-BCMA CAR-POSITIVE VIABLE T CELLS1111

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    59572-515-011 SUSPENSION in 1 BAG
    59572-515-031 SUSPENSION in 1 BAG

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 59572-515-02?

    The NDC Packaged Code 59572-515-02 is assigned to a package of 1 suspension in 1 bag of Abecma, a cellular therapy labeled by Celgene Corporation. The product's dosage form is suspension and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 59572-515 included in the NDC Directory?

    Yes, Abecma with product code 59572-515 is active and included in the NDC Directory. The product was first marketed by Celgene Corporation on March 26, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 59572-515-02?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 59572-515-02?

    The 11-digit format is 59572051502. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-259572-515-025-4-259572-0515-02